Training activity information

Details

Assist with the preparation of cases to be discussed and reviewed in a multidisciplinary team meeting or GTAB meeting with other healthcare professionals

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

  • The role of molecular results to aid diagnosis and direct treatment
  • NICE guidance, clinical trials and the cancer drug fund

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

  • Consider the role of these meetings in the diagnosis, classification, monitoring, and management of haematological malignancies.
  • What types of information are typically required for presentation in these meetings, such as patient history, laboratory results (including genomics), and imaging findings?
  • Who are the key healthcare professionals involved in these meetings and what are their respective roles and perspectives?
  • What is the typical format for presenting a case, and what level of detail is usually required?
  • How can you effectively summarise complex laboratory findings for a multidisciplinary audience?
  • Review the relevant patient data and reports, ensuring you understand the key findings.
  • Consider potential questions that might arise during the meeting and how the information you prepare can help address them.
  • Think about how you can contribute effectively to the preparation process, ensuring all necessary information is clearly and concisely presented.

In action

  • What are you doing to assist with the preparation of the case? What information are you actively gathering and how are you organising it for presentation?
  • What decisions are you making about which information is most relevant and how to present it concisely for the multidisciplinary team (MDT) or Genomic Tumour Advisory Board (GTAB) meeting?
  • How effectively do you feel you are contributing to the case preparation? Are you facing any challenges in accessing necessary information or understanding the clinical context?
  • What can you learn about the types of information and the format of presentation that are most valued in these meetings as you prepare the case?
  • How are you adapting your approach based on the specific requirements of the case or the anticipated needs of the MDT/GTAB members? Are you considering alternative ways to present the data?

On action

  • What did you notice during the process of assisting with the preparation of cases for the Multidisciplinary Team (MDT) or Genomic Tumour Advisory Board (GTAB) meeting? Consider the types of information prioritised, the format of presentation, and the perspectives of different healthcare professionals.
  • What did you learn about the specific genomic information and clinical context that is most relevant for discussion in an MDT or GTAB meeting for haematological malignancies? How does genomic testing contribute to the overall patient pathway? Were there any unexpected challenges or successes in gathering the necessary information or presenting it concisely? What were the key learning points about interprofessional communication and case presentation?
  • What will you take from this experience moving forward in your approach to preparing cases for MDT/GTAB meetings and engaging with colleagues from different specialties? What areas for continued development have been identified, such as improving your ability to synthesise complex genomic data for clinical discussion or understanding the specific needs of different MDT members? How can you apply the learning from this activity to your routine practice, ensuring that genomic findings are effectively integrated into the broader clinical context and communicated clearly to relevant stakeholders? Identify the actions you will take to improve your contribution to MDT/GTAB meetings, such as observing more meetings or seeking feedback on your case preparation.

Beyond action

  • Compare these experiences with any subsequent involvement in MDT/GTAB meetings, whether through observation or active participation. Have you noticed any changes in the focus of discussions or the way genomic information is integrated into clinical decision-making?
  • Have your insights into the crucial data points to highlight or the most effective ways to present laboratory findings in this forum evolved?
  • Have discussions about the effectiveness of MDT/GTAB meetings highlighted different approaches to case preparation or communication?
  • How have subsequent experiences enhanced your understanding of the importance of effective communication and collaboration within a multidisciplinary setting for patient care?
  • Are you now more mindful of the needs of different specialities when preparing or discussing laboratory results?
  • How will you continue to refine your ability to contribute effectively to MDT/GTAB meetings as you progress in your career?

Relevant learning outcomes

# Outcome
# 4 Outcome

Analyse, interpret and prepare interpretive reports for common haematological malignancies, including results for somatic variants, kinase domain mutations, minimal residual disease and post-transplant monitoring.

# 6 Outcome

Practice with the relevant specialities for the diagnosis, monitoring and management of haematological malignancies.